羚邦(02230.HK)與嗶哩嗶哩(09626.HK)達成國漫出海戰略合作
羚邦集團(02230.HK)宣佈,與嗶哩嗶哩(09626.HK)就「國漫出海」達成戰略合作,將負責嗶哩嗶哩旗下《天官賜福》、《時光代理人》、《鎮魂街》等逾30部國產動畫,在東南亞的地區獨家發行及品牌授權的權利,加速國漫出海策略。
另外,羚邦宣佈將投資國產原創動畫《奶龍小七大戰暴暴龍》,並將代理「奶龍」品牌全球發行及品牌授權業務,預期透過集團的IP管理經驗、國際化營運思維、專業授權團隊以及豐富的品牌授權客戶資源,可將「奶龍」打造成爲具有國際影響力的國漫IP,在海內外市場拓展更多商機。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.